| Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy F Aliabadi, B Sohrabi, E Mostafavi, H Pazoki-Toroudi, TJ Webster Open Biology 11 (4), 200390, 2021 | 59 | 2021 |
| Role of polyphenols on gut microbiota and the ubiquitin-proteasome system in neurodegenerative diseases H Nargeh, F Aliabadi, M Ajami, H Pazoki-Toroudi Journal of Agricultural and Food Chemistry 69 (22), 6119-6144, 2021 | 21 | 2021 |
| Why does COVID‐19 pathology have several clinical forms? F Aliabadi, M Ajami, H Pazoki–Toroudi BioEssays 42 (12), 2000198, 2020 | 8 | 2020 |
| Dose COVID-19 Uncovered a New Feature of Metronidazole Drug? Dose COVID-19 Uncover a New Feature of Metronidazole Drug? M Seyedhamzeh, S Javanshir, F Aliabadi, H Reyhanfard, ... | 2 | 2020 |
| The potential of JAK/STAT pathway inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 M Seyedhamzeh, HO Othman, S Aa, F Aliabadi, H Pazoki-Toroudi | | 2020 |
Beheshteh SohrabiDepartment of Chemistry, Surface Chemistry Research Laboratory, Iran University of Science and在 iust.ac.ir 的电子邮件经过验证
Beheshteh SohrabiDepartment of Chemistry, Surface Chemistry Research Laboratory, Iran University of Science and在 iust.ac.ir 的电子邮件经过验证